ABTEarnings Release财报快讯SEC sourceSEC 来源Source link原始来源August 6, 20262026/8/6by InvestLog AIInvestLog AI 整理

Abbott Laboratories (ABT) 2026 Q2 period ended 2026-06-30 financial resultsAbbott Laboratories (ABT) 2026 Q2 period ended 2026-06-30 财报发布

Key Results

Abbott Laboratories reported revenue $12.6B, operating profit $1.8B, net income $928M, operating margin 14.2%.

Period: 2026 Q2 period ended 2026-06-30

Revenue: $12.6B; YoY: +13.0%; QoQ: +12.8%

Gross profit: $7.3B; Gross margin: 58.0%

Operating income: $1.8B; Operating margin: 14.2%; YoY: -13.2%; QoQ: -3.3%

Net income: $928M; GAAP diluted EPS: $0.53; YoY: -47.8%; QoQ: -13.8%

Operating cash flow: $2.5B; Capex: $399M; Free cash flow: $2.1B

Cash: $5.1B; Total debt: $32.6B; Net debt: $27.5B

Official release: 10-Q

Abbott Laboratories 公布2026 Q2 period ended 2026-06-30财报：营收 $12.6B，营业利润 $1.8B，净利润 $928M，营业利润率 14.2%。

期间：2026 Q2 period ended 2026-06-30

营收：$12.6B；同比：+13.0%；环比：+12.8%

毛利润：$7.3B；毛利率：58.0%

经营利润：$1.8B；经营利润率：14.2%；同比：-13.2%；环比：-3.3%

净利润：$928M；GAAP 稀释 EPS：$0.53；同比：-47.8%；环比：-13.8%

经营现金流：$2.5B；资本开支：$399M；自由现金流：$2.1B

现金：$5.1B；总债务：$32.6B；净债务：$27.5B

For information only. Not investment advice.内容仅供参考，不构成投资建议。